Bon Health review

Almost every prepay structure in this category works the same way. Publish the monthly division, leave the amount actually charged for the checkout page, and let the reader discover at the till that a plan advertised at a low monthly figure means well over a thousand dollars leaving the account at once. Bon Health publishes both, on every rung, in the same row: the amount billed, the interval it recurs on, and the per-month figure that division produces. Nothing else we have looked at does this, and it makes the trade completely legible — you can see exactly what committing buys and exactly what it costs up front, before deciding. The month-to-month rung is priced too, which matters just as much, because a ladder with no monthly option is a commitment dressed up as a choice. The rest is solid rather than remarkable. Both compounding pharmacy classes are named repeatedly across the site, cancellation is described in plain terms, and no milligram is published against any figure — so the ladder describes a plan rather than a quantity of drug.

Vs median

$155/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Standard plan, self-directed low dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Check plan terms

Bon Health says it uses 503A or 503B pharmacies, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.

Almost every prepay structure in this category works the same way: publish the monthly division, leave the amount actually charged for the checkout page, and let a reader discover at the till that a $195 plan means $1,170 leaving the account at once. Bon Health publishes both, on every rung, in the same row — the billed amount, the interval it recurs on, and the per-month figure that division produces. Nothing else found so far does this, and it makes the trade completely legible: a reader can see exactly what committing buys and exactly what it costs up front. The month-to-month rung is priced too, which matters as much, because a ladder with no monthly rung is a commitment dressed as a choice. The rest is solid rather than remarkable. Both pharmacy classes are named repeatedly, cancellation is described in plain terms across the site, and no milligram is published against any figure, so the ladder describes a plan rather than a quantity of drug.

The month-to-month rate is the highest on the ladder by a wide margin.

• The published rungs are for the dual-agonist line; the other molecule is priced separately.
• No milligram is published against any rung.

Bon Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Low dose vs full dose
• The true annual cost of a plan
• What a flat price costs at a low dose